BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 19076135)

  • 1. Can we avoid surgery in elderly patients with renal masses by using the Charlson comorbidity index?
    O'Connor KM; Davis N; Lennon GM; Quinlan DM; Mulvin DW
    BJU Int; 2009 Jun; 103(11):1492-5. PubMed ID: 19076135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active surveillance for selected patients with renal masses: updated results with long-term follow-up.
    Abou Youssif T; Kassouf W; Steinberg J; Aprikian AG; Laplante MP; Tanguay S
    Cancer; 2007 Sep; 110(5):1010-4. PubMed ID: 17628489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of renal masses in patients medically unsuitable for nephrectomy--natural history, complications, and outcome.
    Lamb GW; Bromwich EJ; Vasey P; Aitchison M
    Urology; 2004 Nov; 64(5):909-13. PubMed ID: 15533476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Observation should be considered as an alternative in management of renal masses in older and comorbid patients.
    Beisland C; Hjelle KM; Reisaeter LA; Bostad L
    Eur Urol; 2009 Jun; 55(6):1419-27. PubMed ID: 19147267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A preoperative prognostic nomogram for solid enhancing renal tumors 7 cm or less amenable to partial nephrectomy.
    Lane BR; Babineau D; Kattan MW; Novick AC; Gill IS; Zhou M; Weight CJ; Campbell SC
    J Urol; 2007 Aug; 178(2):429-34. PubMed ID: 17561141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidentally discovered renal masses: oncological and perioperative outcomes in patients with delayed surgical intervention.
    Rais-Bahrami S; Guzzo TJ; Jarrett TW; Kavoussi LR; Allaf ME
    BJU Int; 2009 May; 103(10):1355-8. PubMed ID: 19239459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nephron-sparing surgery for renal cell carcinoma in the solitary kidney.
    Berdjis N; Hakenberg OW; Novotny V; Manseck A; Oehlschläger S; Wirth MP
    Scand J Urol Nephrol; 2007; 41(1):10-3. PubMed ID: 17366096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The growth rate of large renal masses opposes active surveillance.
    Staehler M; Haseke N; Stadler T; Zilinberg E; Nordhaus C; Nuhn P; Khoder WY; Karl A; Stief CG
    BJU Int; 2010 Apr; 105(7):928-31. PubMed ID: 19751265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Watchful waiting for solid renal masses: insight into the natural history and results of delayed intervention.
    Kouba E; Smith A; McRackan D; Wallen EM; Pruthi RS
    J Urol; 2007 Feb; 177(2):466-70; discussion 470. PubMed ID: 17222611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intermediate comparison of partial nephrectomy and radiofrequency ablation for clinical T1a renal tumours.
    Stern JM; Svatek R; Park S; Hermann M; Lotan Y; Sagalowsky AI; Cadeddu JA
    BJU Int; 2007 Aug; 100(2):287-90. PubMed ID: 17617136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Active surveillance of renal masses in elderly patients.
    Abouassaly R; Lane BR; Novick AC
    J Urol; 2008 Aug; 180(2):505-8; discussion 508-9. PubMed ID: 18550113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The natural history of observed enhancing renal masses: meta-analysis and review of the world literature.
    Chawla SN; Crispen PL; Hanlon AL; Greenberg RE; Chen DY; Uzzo RG
    J Urol; 2006 Feb; 175(2):425-31. PubMed ID: 16406965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conservative management of small renal tumors.
    Matsuzaki M; Kawano Y; Morikawa H; Shiga Y; Murata H; Komatsu H
    Hinyokika Kiyo; 2007 Apr; 53(4):207-11. PubMed ID: 17515068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active surveillance of small renal masses offers short-term oncological efficacy equivalent to radical and partial nephrectomy.
    Patel N; Cranston D; Akhtar MZ; George C; Jones A; Leiblich A; Protheroe A; Sullivan M
    BJU Int; 2012 Nov; 110(9):1270-5. PubMed ID: 22564495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy.
    Thompson RH; Boorjian SA; Lohse CM; Leibovich BC; Kwon ED; Cheville JC; Blute ML
    J Urol; 2008 Feb; 179(2):468-71; discussion 472-3. PubMed ID: 18076931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Re-evaluation of the Tumour-Node-Metastasis staging of locally advanced renal cortical tumours: absolute size (T2) is more significant than renal capsular invasion (T3a).
    Murphy AM; Gilbert SM; Katz AE; Goluboff ET; Sawczuk IS; Olsson CA; Benson MC; McKiernan JM
    BJU Int; 2005 Jan; 95(1):27-30. PubMed ID: 15638890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A population-based comparison of survival after nephrectomy vs nonsurgical management for small renal masses.
    Zini L; Perrotte P; Jeldres C; Capitanio U; Duclos A; Jolivet-Tremblay M; Arjane P; Péloquin F; Pharand D; Villers A; Montorsi F; Patard JJ; Karakiewicz PI
    BJU Int; 2009 Apr; 103(7):899-904; discussion 904. PubMed ID: 19154499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transperitoneal laparoscopic radical nephrectomy for large (more than 7 cm) renal masses.
    Berger AD; Kanofsky JA; O'Malley RL; Hyams ES; Chang C; Taneja SS; Stifelman MD
    Urology; 2008 Mar; 71(3):421-4. PubMed ID: 18342177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of nephron-sparing surgery for T1b renal cell carcinoma.
    Joniau S; Vander Eeckt K; Srirangam SJ; Van Poppel H
    BJU Int; 2009 May; 103(10):1344-8. PubMed ID: 19040528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor size is a determinant of the rate of stage T1 renal cell cancer synchronous metastasis.
    Lughezzani G; Jeldres C; Isbarn H; Perrotte P; Shariat SF; Sun M; Widmer H; Arjane P; Peloquin F; Pharand D; Patard JJ; Graefen M; Montorsi F; Karakiewicz PI
    J Urol; 2009 Oct; 182(4):1287-93. PubMed ID: 19683281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.